4//SEC Filing
Finley John David 4
Accession 0001493152-24-021045
CIK 0001357459other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:52 PM ET
Size
6.3 KB
Accession
0001493152-24-021045
Insider Transaction Report
Form 4
Finley John David
DirectorCEO, CFO
Transactions
- Award
Common Stock, par value $0.01
2024-05-20$4.97/sh+666$3,312→ 7,437 total
Holdings
- 51(indirect: By LLC)
Common Stock, par value $0.01
Footnotes (2)
- [F1]Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024.
- [F2]Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001851034
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:52 PM ET
- Size
- 6.3 KB